Duggan now at 8.62M shares @ $13.81/sh, $119M total
as we predicted days ago, he was still bottom fishing for shares.
He may or may not continue his patient bottom fishing,
but when done he probably will buy SP up and squeeze.
He waited a long time until this very moment until company
has released the 'crunch time' status for being available for buyout.
Company's unwillingness to utilize the ATM and negotiate w/ SVB might have something to do with that, as well as dropping from the Evercore investor's conference. They might not need new buyers for shares or suitors anymore.
Instead, company participates on biotech conferences this December.
Around $500M R&D were spent to develop the pipeline and AB,
this would be $8.94/sh after total liabilities of $87.52M with an OS of 46.12M.
as we predicted days ago, he was still bottom fishing for shares.
He may or may not continue his patient bottom fishing,
but when done he probably will buy SP up and squeeze.
He waited a long time until this very moment until company
has released the 'crunch time' status for being available for buyout.
Company's unwillingness to utilize the ATM and negotiate w/ SVB might have something to do with that, as well as dropping from the Evercore investor's conference. They might not need new buyers for shares or suitors anymore.
Instead, company participates on biotech conferences this December.
Around $500M R&D were spent to develop the pipeline and AB,
this would be $8.94/sh after total liabilities of $87.52M with an OS of 46.12M.
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
